R01 AI052367/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2001	1
2002	1
2005	1
2006	2
2007	2
2008	1
2012	3
2013	4
2014	2
2016	1
2024	0

1

Vaccine platforms to control Lassa fever.

Lukashevich IS, Pushko P. Lukashevich IS, et al. Expert Rev Vaccines. 2016 Sep;15(9):1135-50. doi: 10.1080/14760584.2016.1184575. Epub 2016 May 24. Expert Rev Vaccines. 2016. PMID: 27136941 Review.

2

The search for animal models for Lassa fever vaccine development.

Lukashevich IS. Lukashevich IS. Expert Rev Vaccines. 2013 Jan;12(1):71-86. doi: 10.1586/erv.12.139. Expert Rev Vaccines. 2013. PMID: 23256740 Free PMC article. Review.

3

Advanced vaccine candidates for Lassa fever.

Lukashevich IS. Lukashevich IS. Viruses. 2012 Oct 29;4(11):2514-57. doi: 10.3390/v4112514. Viruses. 2012. PMID: 23202493 Free PMC article. Review.

4

Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

Carrion R Jr, Bredenbeek P, Jiang X, Tretyakova I, Pushko P, Lukashevich IS. Carrion R Jr, et al. J Vaccines Vaccin. 2012 Nov 20;3(7):1000160. doi: 10.4172/2157-7560.1000160. J Vaccines Vaccin. 2012. PMID: 23420494 Free PMC article.

5

Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression.

Lukashevich IS, Maryankova R, Vladyko AS, Nashkevich N, Koleda S, Djavani M, Horejsh D, Voitenok NN, Salvato MS. Lukashevich IS, et al. J Med Virol. 1999 Dec;59(4):552-60. J Med Virol. 1999. PMID: 10534741 Free PMC article.

6

An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.

Zapata JC, Poonia B, Bryant J, Davis H, Ateh E, George L, Crasta O, Zhang Y, Slezak T, Jaing C, Pauza CD, Goicochea M, Moshkoff D, Lukashevich IS, Salvato MS. Zapata JC, et al. Virol J. 2013 Feb 12;10:52. doi: 10.1186/1743-422X-10-52. Virol J. 2013. PMID: 23402317 Free PMC article.

7

Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.

Moshkoff DA, Salvato MS, Lukashevich IS. Moshkoff DA, et al. Virus Genes. 2007 Apr;34(2):169-76. doi: 10.1007/s11262-006-0050-3. Epub 2006 Dec 2. Virus Genes. 2007. PMID: 17143722 Free PMC article.

8

A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS. Lukashevich IS, et al. J Virol. 2005 Nov;79(22):13934-42. doi: 10.1128/JVI.79.22.13934-13942.2005. J Virol. 2005. PMID: 16254329 Free PMC article.

9

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.

Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J, Carrion R, Ticer A, Brasky K, Lukashevich IS. Bredenbeek PJ, et al. Virology. 2006 Feb 20;345(2):299-304. doi: 10.1016/j.virol.2005.12.001. Epub 2006 Jan 18. Virology. 2006. PMID: 16412488 Free PMC article.

10

Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.

Tretyakova I, Nickols B, Hidajat R, Jokinen J, Lukashevich IS, Pushko P. Tretyakova I, et al. Virology. 2014 Nov;468-470:28-35. doi: 10.1016/j.virol.2014.07.050. Epub 2014 Aug 16. Virology. 2014. PMID: 25129436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year